Stay updated on Liraglutide in Prader-Willi Syndrome: Pediatric Weight Clinical Trial
Sign up to get notified when there's something new on the Liraglutide in Prader-Willi Syndrome: Pediatric Weight Clinical Trial page.

Latest updates to the Liraglutide in Prader-Willi Syndrome: Pediatric Weight Clinical Trial page
- Check2 days agoChange DetectedA banner announces that NIH is transitioning to use “Super Intelligence” instead of “Artificial Intelligence” in agency content, with updates and FAQs available.SummaryDifference1%

- Check9 days agoChange DetectedThe site's footer revision label changes from v3.7.1 to v3.7.2, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.SummaryDifference0.2%

- Check37 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the study record content. This replaces the visible sponsor, location, and document sections with an error page, effectively concealing the record.SummaryDifference24%

- Check58 days agoChange DetectedNIH grant/contract year 2014 has been added. The site revision is updated to v3.6.6, replacing the earlier v3.6.5 entry.SummaryDifference0.1%

- Check80 days agoChange DetectedThe revision tag changed from v3.6.4 to v3.6.5, marking a new version of the page/document. This appears to be a minor update with no explicit content changes shown.SummaryDifference0.0%

Stay in the know with updates to Liraglutide in Prader-Willi Syndrome: Pediatric Weight Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Liraglutide in Prader-Willi Syndrome: Pediatric Weight Clinical Trial page.